Bristol-Myers Squibb Ups its Plans for China

Bristol-Myers Squibb expects China to become its second or third largest market within a decade. That’s a big jump from eighth place currently and a projected sixth next year. To get this task accomplished, BMS will increase its R&D staff in Shanghai, and it plans to increase its number of collaborations with domestic China pharmas. More details.... Stock Symbol: (NYSE: BMY)     Share this with colleagues:    
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.